Ads
related to: Treatment Macular Degeneration and Aflibercept
Search results
Health Care Roundup: Market Talk
The Wall Street Journal· 3 days agoThe Swiss pharmaceutical company’s drug adalimumab, for the treatment of autoimmune diseases, is likely to gain better-than-expected market sharedue to...
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC...
Napa Valley Register· 3 days agoPharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next generation therapeutics to treat medical unmet needs, announced today that ...
Byooviz dosage: Form, strength, when to use, and more
Medical News Today· 1 week agoByooviz (ranibizumab-nuna) is a brand-name drug prescribed for certain eye conditions in adults. It...
Ad
related to: Treatment Macular Degeneration and Aflibercept
